News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

SciClone Pharmaceuticals, Inc. (SCLN) Selects rfXcel To Meet China Product Compliance And Anti-Counterfeiting Goal


4/23/2014 7:42:54 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN RAMON, Calif.--(BUSINESS WIRE)--rfXcel, a leading cloud provider of product serialization, traceability and compliance solutions, announces that SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN), a US-based, specialty pharmaceutical company with a substantial commercial business in China, has selected rfXcel Traceability SystemTM (rTS) to meet its China product compliance needs and further advance its ongoing efforts to minimize counterfeiting of its proprietary products in China.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES